| Tango Therapeutics, Inc. | 10.5M | US$263M | 22.8% |
| Kodiak Sciences Inc | 1.48M | US$140M | 12.2% |
| Revolution Medicines, Inc. | 500K | US$103M | 8.9% |
| Kymera Therapeutics, Inc. | 525K | US$58.6M | 5.1% |
| Replimune Group, Inc. | 4.28M | US$56.6M | 4.9% |
| Abivax SA | 475K | US$47M | 4.1% |
| Surrozen, Inc. | 1.36M | US$43.8M | 3.8% |
| Corcept Therapeutics Incorporated | 336K | US$38.7M | 3.4% |
| Precigen, Inc. | 4.32M | US$37M | 3.2% |
| Definium Therapeutics, Inc. | 684K | US$26M | 2.3% |
| Amylyx Pharmaceuticals, Inc. | 893K | US$26M | 2.3% |
| Spyre Therapeutics, Inc. | 283K | US$25.2M | 2.2% |
| Protagonist Therapeutics, Inc. | 170K | US$24M | 2.1% |
| Celcuity Inc. | 286K | US$22.8M | 2.0% |
| Opus Genetics, Inc. | 4.53M | US$21.9M | 1.9% |
| Q32 Bio Inc. | 2.58M | US$21.3M | 1.9% |
| Achieve Life Sciences, Inc. | 2.15M | US$17.4M | 1.5% |
| C4 Therapeutics, Inc. | 4.15M | US$13.8M | 1.2% |
| First Tracks Biotherapeutics, Inc. | 240K | US$8.51M | 0.74% |
| Shattuck Labs, Inc. | 1.18M | US$8.02M | 0.70% |
| SAB Biotherapeutics, Inc. | 2.5M | US$7.92M | 0.69% |
| Cullinan Therapeutics, Inc. | 450K | US$6.91M | 0.60% |
| Contineum Therapeutics, Inc. | 494K | US$6.63M | 0.58% |
| Cytokinetics, Incorporated | 100K | US$6.59M | 0.57% |
| Palisade Bio, Inc. | 4.8M | US$6.48M | 0.56% |
| Capricor Therapeutics, Inc. | 643K | US$6.09M | 0.53% |
| Electra Therapeutics, Inc. | 450K | US$5.06M | 0.44% |
| AN2 Therapeutics, Inc. | 944K | US$5.02M | 0.44% |
| Maze Therapeutics, Inc. | 175K | US$4.77M | 0.41% |
| Edesa Biotech, Inc. | 937K | US$3.95M | 0.34% |
| Relay Therapeutics, Inc. | 200K | US$3.61M | 0.31% |
| Kazia Therapeutics Ltd | 372K | US$3.56M | 0.31% |
| Attovia Therapeutics, Inc. | 200K | US$3.43M | 0.30% |
| PMV Pharmaceuticals, Inc. | 2.05M | US$3.42M | 0.30% |
| Zentalis Pharmaceuticals, Inc. | 1.01M | US$2.81M | 0.24% |
| Sarepta Therapeutics, Inc. | 150K | US$2.73M | 0.24% |
| Allogene Therapeutics, Inc. | 1.5M | US$2.4M | 0.21% |
| Nurix Therapeutics, Inc. | 100K | US$2.37M | 0.21% |
| Sionna Therapeutics, Inc. | 392K | US$2.06M | 0.18% |
| Clene Inc. | 478K | US$1.95M | 0.17% |
| Aclaris Therapeutics, Inc. | 300K | US$1.58M | 0.14% |
| Milestone Pharmaceuticals Inc. | 667K | US$577K | 0.05% |
| Neumora Therapeutics, Inc. | 954K | US$569K | 0.05% |
| Karyopharm Therapeutics Inc. | 128K | US$156K | 0.01% |
| Regenxbio Inc. | 0 | US$0 | 0.00% |
| Relmada Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Solid Biosciences Inc. | 0 | US$0 | 0.00% |
| Upstream Bio, Inc. | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Vir Biotechnology, Inc. | 0 | US$0 | 0.00% |
| Zura Bio Limited | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cogent Biosciences, Inc. | 0 | US$0 | 0.00% |
| Corvus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Cybin, Inc. | 0 | US$0 | 0.00% |
| Sensei Biotherapeutics, Inc. | 0 | US$0 | 0.00% |
| Forte Biosciences, Inc. | 0 | US$0 | 0.00% |
| Inovio Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Invivyd, Inc. | 0 | US$0 | 0.00% |
| LB Pharmaceuticals Inc | 0 | US$0 | 0.00% |
| MapLight Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ocular Therapeutix, Inc. | 0 | US$0 | 0.00% |
| Odyssey Therapeutics, Inc. | 0 | US$0 | 0.00% |
| ORIC Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| PepGen Inc. | 0 | US$0 | 0.00% |
| Praxis Precision Medicines, Inc. | 0 | US$0 | 0.00% |
| PTC Therapeutics, Inc. | 0 | US$0 | 0.00% |